Related Experiment Videos
Extracorporeal membrane oxygenation (ECMO) for neonatal respiratory failure
1Division of Cardiothoracic Surgery, University of Texas Medical Branch, Galveston.
The Thoracic and Cardiovascular Surgeon
|December 11, 1992
Summary
Extracorporeal membrane oxygenation (ECMO) offers an 82% survival rate for neonates with severe respiratory failure. This advanced life support is the preferred treatment for newborns facing critical breathing issues.
Area of Science:
- Neonatal care
- Cardiopulmonary bypass technologies
Background:
- Severe respiratory failure poses a high mortality risk in neonates.
- Extracorporeal membrane oxygenation (ECMO) has emerged as a life-saving intervention.
Purpose of the Study:
- To review the indications for neonatal ECMO.
- To summarize complications associated with ECMO.
- To discuss future applications of ECMO in neonates.
Main Methods:
- Extracorporeal membrane oxygenation (ECMO) involves prolonged extracorporeal cardiopulmonary bypass.
- Utilizes extrathoracic vascular cannulation and a modified heart-lung machine.
Main Results:
- ECMO demonstrates an 82% survival rate in over 5000 treated neonates.
- Without ECMO, mortality for severe respiratory failure in neonates is predicted at 80%.
Conclusions:
- ECMO is the current treatment of choice for term newborns with severe respiratory failure.
- Understanding indications and complications is crucial for optimal ECMO use.
- Further applications of neonatal ECMO are anticipated.